IPO screener: Jhunjhunwala-backed Concord Biotech to hit Street today thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.
Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.
Stock exchange data also showed that Think India Opportunities Master Fund LP and Multiplier Share and Stock Advisors Private Limited also purchased 58 lakh and 10 lakh shares respectively at an average price of Rs 61.65 per equity share.
Concord Biotech IPO | The Ahmedabad-based company has informed exchanges that it has finalised allocation of 62,74,695 equity shares to anchor investors at upper price band of Rs 741 per share.